GoodRx

Congratulations to the GoodRx Product Design team for winning 12 DANDA awards that recognize outstanding design work across GoodRx Health, the GoodRx Rewards program, and the GoodRx platform for healthcare professionals (HCPs)! At GoodRx we meticulously design and develop our products, content, and services with patients and their HCPs at the center, supporting our mission to build better ways for people to access affordable medications to improve their health outcomes. See all the DANDA winners at: https://lnkd.in/eGdKPkbt

🎁  GoodRx'ers Give Back This Holiday Season! 🎁 This holiday season, our GoodRx team embodied the spirit of giving across the country. From coast to coast, our employees came together to support their communities in meaningful ways. In San Francisco, our employees assembled 100 hygiene kits for Simply the Basics, providing essential items to those in need. At our New York hub, employees created sensory toy kits for children with autism from the Brooklyn Institute, spreading smiles and comfort. In Seattle, we had a team participate in the Cinematique community event with Essex Community Outreach, helping to distribute vital health resources for families in need. In Los Angeles, our employees donated toys and attended the Winter Wonderland Community Event, hosted by Be Social Productions, bringing health screenings, community resources, and holiday cheer to more than 800 families. Across the country, our remote GoodRx'ers recorded audiobooks for hospitalized children, sharing stories and hope during challenging times. We’re proud to see our team living out our values and making a difference. Here’s to a joyful holiday season and to building healthier, happier communities—together. 💛

How easy is it to access an endocrinologist? In our latest report, GoodRx Research found that nearly 70% of U.S. counties — or 50 million Americans — in the U.S. lack access to an endocrinologist. See how this can directly impact outcomes for people with common conditions such as diabetes, thyroid disorders, and more. #Healthcare #Endocrinology #Research

The news is out: I’ll be embarking on a thrilling new journey next month as president and CEO at GoodRx. For many years, I have admired GoodRx for the company’s simple, yet powerful value proposition – to make it easier for Americans to save time and money when filling their medications. Throughout my career in healthcare, my motivation has always been to improve the patient experience, and I’m honored to take the helm at a company doing just that.  GoodRx sits at a unique intersection within the broader healthcare ecosystem, collaborating with pharmacies, PBMs, pharmaceutical manufacturers and others. I’ve worked for and with many of these organizations and understand that innovation in healthcare is often nuanced and complex. As I step into this role, my goal is clear: to make GoodRx the complement to insurance that fills in the gaps the system doesn’t cover. I want to express my gratitude to Scott Wagner for his leadership and vision as Interim CEO, and to Trevor Bezdek and doug hirsch for building a purpose-driven company that prioritizes transparency and savings so patients can access the treatments they need to stay healthy.  Learn more about my new role and our path forward here: https://lnkd.in/gyqV5TGs

Prescriptions for Wegovy from Novo Nordisk have increased by 100%; meanwhile, prescriptions for Zepbound from Lilly have increased by 300%, according to GoodRx Research. “People tend to assume, ‘I have insurance, I’m covered, I’m going to be paying my normal co-pay.’ And that doesn’t seem to be the case, unfortunately, for these medications,” GoodRx director of research Tori Marsh told Marketplace by APM. However, patients can save an average of $250 per month, or $3,000 annually, on commonly prescribed GLP-1 and GIP medications with GoodRx. Learn more: https://lnkd.in/e34dy4_D

As a heart transplant survivor who relies on 18 medications a day, Lorenzo is always looking for ways to help make his healthcare more affordable. With GoodRx he saves ~$370 each month on his prescriptions. These extra savings allow him to live his life to the fullest, without worrying about how much his medications cost. Check GoodRx and see if you can save. goodrx.co/goodstories

GOOD NEWS today from GoodRx! We are thrilled to announce our VP, Consumer Health and Wellness Sales, Meredith Horton, has been selected for a ‘40 Under 40’ Award by Medical Marketing and Media (MM+M), a premier information resource for healthcare marketing decision makers. Now in its sixth year, MM+M's 40 Under 40 program “celebrates the breadth of high-achieving young professionals working in the realms of medical marketing and healthcare communications.” Meredith will be honored with other ‘40 under 40’ award winners at an event in NYC on February 11th. See you there, and congratulations Meredith! Connect with us here! GoodSolutions@goodrx.com Learn more about MM+M's 40 Under 40: https://lnkd.in/eHjEsykK

GLP-1 drugs like Ozempic and Wegovy have revolutionized how people manage diabetes and weight loss, but they often come at a steep price. Learn ways to save on GLP-1 drugs with this guide.

Demand for popular weight loss meds is not slowing down, but a new data tracker from my team at GoodRx shows how difficult they still are to access and afford. Fills for medications like Wegovy and Zepbound soared in 2024 by more than 100% and 300%, respectively. But in the last year, Americans have overspent by at least $200 million by paying full price for these popular weight loss medications and not utilizing savings available through sites like GoodRx. Even going through insurance can come with high out-of-pocket costs and/or restrictions. Making these medications more affordable and accessible is key, both to getting – and keeping – people on the medications they need. At GoodRx we’re doing this by making it easier for people (85% of whom already have a prescription in hand) to uncover manufacturer savings and copay cards for GIP and GLP-1 agonists. But there’s still so much more we can do as an industry. https://lnkd.in/eEXW972u #GoodRx #WeightLossMedications #GLP1

“It’s just a pretty astronomical increase in sales, and because of that, a lot of eyes are on them around their affordability and accessibility,” GoodRx director of research Tori Marsh told CNBC. People without insurance can save an average of $250 monthly, or $3,000 annually, using GoodRx. In the past year, Americans have overspent by at least $200 million by paying full retail price for GIP and GLP-1 agonists.